Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase
- PMID: 7935441
- PMCID: PMC359261
- DOI: 10.1128/mcb.14.11.7265-7275.1994
Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase
Abstract
The assembly of functional holoenzymes composed of regulatory D-type cyclins and cyclin-dependent kinases (cdks) is rate limiting for progression through the G1 phase of the mammalian somatic cell cycle. Complexes between D-type cyclins and their major catalytic subunit, cdk4, are catalytically inactive until cyclin-bound cdk4 undergoes phosphorylation on a single threonyl residue (Thr-172). This step is catalyzed by a cdk-activating kinase (CAK) functionally analogous to the enzyme which phosphorylates cdc2 and cdk2 at Thr-161/160. Here, we demonstrate that the catalytic subunit of mouse cdc2/cdk2 CAK (a 39-kDa protein designated p39MO15) can assemble with a regulatory protein present in either insect or mammalian cells to generate a CAK activity capable of phosphorylating and enzymatically activating both cdk2 and cdk4 in complexes with their respective cyclin partners. A newly identified 37-kDa cyclin-like protein (cyclin H [R. P. Fisher and D. O. Morgan, Cell 78:713-724, 1994]) can assemble with p39MO15 to activate both cyclin A-cdk2 and cyclin D-cdk4 in vitro, implying that CAK is structurally reminiscent of cyclin-cdk complexes themselves. Antisera produced to the p39MO15 subunit can completely deplete mammalian cell lysates of CAK activity for both cyclin A-cdk2 and cyclin D-cdk4, with recovery of activity in the resulting immune complexes. By using an immune complex CAK assay, CAK activity for cyclin A-cdk2 and cyclin D-cdk4 was detected both in quiescent cells and invariantly throughout the cell cycle. Therefore, although it is essential for the enzymatic activation of cyclin-cdk complexes, CAK appears to be neither rate limiting for the emergence of cells from quiescence nor subject to upstream regulatory control by stimulatory mitogens.
Similar articles
-
A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase.Cell. 1994 Aug 26;78(4):713-24. doi: 10.1016/0092-8674(94)90535-5. Cell. 1994. PMID: 8069918
-
Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase.Mol Cell Biol. 1994 Apr;14(4):2713-21. doi: 10.1128/mcb.14.4.2713-2721.1994. Mol Cell Biol. 1994. PMID: 8139570 Free PMC article.
-
B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors.J Immunol. 1999 Sep 15;163(6):3160-8. J Immunol. 1999. PMID: 10477583
-
The cdk-activating kinase (CAK): from yeast to mammals.Cell Mol Life Sci. 1999 Feb;55(2):284-96. doi: 10.1007/s000180050290. Cell Mol Life Sci. 1999. PMID: 10188587 Free PMC article. Review.
-
Cyclin-dependent kinases. CAK-handed kinase activation.Curr Biol. 1995 Jan 1;5(1):40-2. doi: 10.1016/s0960-9822(95)00013-3. Curr Biol. 1995. PMID: 7697347 Review.
Cited by
-
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer.Clin Cancer Res. 2024 May 1;30(9):1889-1905. doi: 10.1158/1078-0432.CCR-23-2975. Clin Cancer Res. 2024. PMID: 38381406 Free PMC article.
-
Unveiling the noncanonical activation mechanism of CDKs: insights from recent structural studies.Front Mol Biosci. 2023 Nov 9;10:1290631. doi: 10.3389/fmolb.2023.1290631. eCollection 2023. Front Mol Biosci. 2023. PMID: 38028546 Free PMC article. Review.
-
Oxoglutarate dehydrogenase-like inhibits the progression of hepatocellular carcinoma by inducing DNA damage through non-canonical function.Cell Death Differ. 2023 Aug;30(8):1931-1942. doi: 10.1038/s41418-023-01186-1. Epub 2023 Jul 7. Cell Death Differ. 2023. PMID: 37419985 Free PMC article.
-
Functional characterization of the human Cdk10/Cyclin Q complex.Open Biol. 2022 Mar;12(3):210381. doi: 10.1098/rsob.210381. Epub 2022 Mar 16. Open Biol. 2022. PMID: 35291876 Free PMC article.
-
Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27.Cell Cycle. 2022 Jan;21(1):12-32. doi: 10.1080/15384101.2021.1984663. Epub 2021 Dec 16. Cell Cycle. 2022. PMID: 34913830 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous